News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Nektar Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
For Sale: Nektar Therapeutics Plans to License Hot New Opioid Drug
March 20, 2017
·
3 min read
Drug Development
Nektar Therapeutics To Present At Jefferies Autumn 2015 Global Healthcare Conference In London
November 17, 2015
·
2 min read
Drug Development
Nektar Therapeutics Chief Science Officer Provides Details on Immuno-Oncology, Pain Pipelines
October 9, 2015
·
4 min read
Business
EXCLUSIVE: Nektar Therapeutics, University of Texas MD Anderson Cancer Center Team Up on Phase 1/2 Trial of NKTR-214
June 2, 2015
·
5 min read
Policy
Nektar Therapeutics Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry
March 17, 2015
·
4 min read
Job Trends
Booming Nektar Therapeutics (CA) Grabs More Mission Bay Space; May Hire Another 150 Staffers
January 20, 2015
·
1 min read
Biotech Bay
Opioids Without Addiction, Nektar Therapeutics (CA) Reveals
September 4, 2013
·
1 min read
BioCapital
The Day In Review: Big M&A Activity In Biotech
September 21, 2006
·
1 min read
Biotech Beach
The Day In Review: Enzon Pharmaceuticals, Inc. Buys And Sells Drug Progams
July 27, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
May 27, 2026
·
1 min read
Press Releases
Nektar Therapeutics Reports First Quarter 2026 Financial Results
May 8, 2026
·
10 min read
Press Releases
Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
April 29, 2026
·
1 min read
Press Releases
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 24, 2026
·
3 min read
Press Releases
Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering
April 22, 2026
·
5 min read
Press Releases
52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
April 20, 2026
·
13 min read
Press Releases
Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026
April 20, 2026
·
2 min read
Press Releases
Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting
March 30, 2026
·
10 min read
Press Releases
Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
March 22, 2026
·
9 min read
Press Releases
Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
March 13, 2026
·
14 min read
